359 related articles for article (PubMed ID: 86163)
21. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
[TBL] [Abstract][Full Text] [Related]
22. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
Bellet D; Caillaud JM; Droz JP; Delarue JC; Bohuon C
Nouv Presse Med; 1981 Nov; 10(40):3293-7. PubMed ID: 6170931
[TBL] [Abstract][Full Text] [Related]
23. Serum alpha-fetoprotein and human chorionic gonadotropin as markers for the effect of postoperative radiation therapy and/or chemotherapy in testicular cancer.
Schultz H; Sell A; Nørgaard-Pedersen B; Arends J
Cancer; 1978 Nov; 42(5):2182-6. PubMed ID: 82474
[TBL] [Abstract][Full Text] [Related]
24. Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
Lange PH; Nochomovitz LE; Rosai J; Fraley EE; Kennedy BJ; Bosl G; Brisbane J; Catalona WJ; Cochran JS; Comisarow RH; Cummings KB; deKernion JB; Einhorn LH; Hakala TR; Jewett M; Moore MR; Scardino PT; Streitz JM
J Urol; 1980 Oct; 124(4):472-8. PubMed ID: 6158584
[TBL] [Abstract][Full Text] [Related]
25. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
[TBL] [Abstract][Full Text] [Related]
26. [Significance of serum ferritin level in testicular tumors].
Takai K; Kojima H; Kume H; Takemura T; Moriyama N; Murahashi I; Aso Y
Hinyokika Kiyo; 1991 Apr; 37(4):357-62. PubMed ID: 1716405
[TBL] [Abstract][Full Text] [Related]
27. Treatment of seminoma: does a positive HCG influence prognosis?
Bartsch G; Mikuz G; Frommhold H; Scheiber K
Prog Clin Biol Res; 1985; 203():483-4. PubMed ID: 2421340
[No Abstract] [Full Text] [Related]
28. Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
Javadpour N; McIntire KR; Waldmann TA
Cancer; 1978 Dec; 42(6):2768-72. PubMed ID: 83187
[TBL] [Abstract][Full Text] [Related]
29. [Studies on the tumor markers in the germinal testicular tumors. Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and carcinoembryonic antigen (CEA) in germinal testicular tumors using an indirect immunoperoxidase method].
Miki T
Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):503-22. PubMed ID: 6206269
[No Abstract] [Full Text] [Related]
30. Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors.
Vogelzang NJ; Lange PH; Goldman A; Vessela RH; Fraley EE; Kennedy BJ
Cancer Res; 1982 Nov; 42(11):4855-61. PubMed ID: 6181870
[TBL] [Abstract][Full Text] [Related]
31. Serum alpha1-fetoprotein and H.C.G. in patients with testicular tumours.
Newlands ES; Dent J; Kardana A; Searle F; Bagshawe KD
Lancet; 1976 Oct; 2(7988):744-5. PubMed ID: 61427
[No Abstract] [Full Text] [Related]
32. [Pregnancy-specific beta 1-glycoprotein: a tumor marker].
Horne CH; Bremner RD
Ric Clin Lab; 1984; 14 Suppl 2():33-8. PubMed ID: 6085182
[No Abstract] [Full Text] [Related]
33. Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors.
Morris MJ; Bosl GJ
J Urol; 2000 Mar; 163(3):796-801. PubMed ID: 10687980
[TBL] [Abstract][Full Text] [Related]
34. Use of human chorionic gonadotropin and alpha-fetoprotein radioimmunoassays: specificity and apparent half-life determination after delivery and in patients with germ cell tumors.
Mann K; Lamerz R; Hellmann T; Kümper HJ; Staehler G; Karl HJ
Oncodev Biol Med; 1980; 1(4-5):301-12. PubMed ID: 6169065
[TBL] [Abstract][Full Text] [Related]
35. [Biological markers in testicular cancer].
Glait HM; Carugati A; Scorticati C; Koss A; Bellora O; Mickiewicz E; Arturi J; Olivari AJ
Medicina (B Aires); 1982; 42(5):488-94. PubMed ID: 6188940
[No Abstract] [Full Text] [Related]
36. Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
Fizazi K; Culine S; Kramar A; Amato RJ; Bouzy J; Chen I; Droz JP; Logothetis CJ
J Clin Oncol; 2004 Oct; 22(19):3868-76. PubMed ID: 15302906
[TBL] [Abstract][Full Text] [Related]
37. Biologic tumor markers in management of testicular and bladder cancer.
Javadpour N
Urology; 1978 Aug; 12(2):177-83. PubMed ID: 80871
[TBL] [Abstract][Full Text] [Related]
38. [Tumor markers in germ cell tumors. Clinical use and research aspects].
Clausen PP; Nørgaard-Pedersen B; Arends J; Ingild A; Jacobsen GK; Jacobsen M; Juhl BR; Kjaersgaard E; Nissen MH; Schultz-Larsen P; Toftager-Larsen K; Zeuthen J
Ugeskr Laeger; 1982 May; 144(18):1285-90. PubMed ID: 6181594
[No Abstract] [Full Text] [Related]
39. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]